Authors : Sakariye Abdullahi Hassan-Tuuryare; Suleyman Abdullahi Mohamed; Timothy Kimutai

Volume/Issue : Volume 9 - 2024, Issue 6 - June

Google Scholar : https://tinyurl.com/2adjtukn

Scribd : https://tinyurl.com/bdhjwj3t

DOI : https://doi.org/10.38124/ijisrt/IJISRT24JUN1232

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Introduction: Brucellosis is a disease that can be contracted by humans through contact with infected animals or animal products. It can be transmitted through contaminated dairy products, so caution must be exercised when handling and preparing food. By taking precautions, the spread of this disease can be mitigated to protect both humans and animals. (1) Brucella spp is a type of bacteria that can cause an infection. The symptoms of this infection can range from mild flu-like symptoms to severe complications that affect different parts of the body. Because Brucella is able to invade the body and avoid the immune system, it's important to get an accurate diagnosis and start treatment as soon as possible. (2). (3)  Method: The study was conducted at Kalkaal Hospital from 2019 to 2023, spanning three years. Patients who went to the hospital's Outpatient department and were screened for Brucella were included in the study. Data on patients' demographics, including their residence, gender, age, and Brucella screening results, were collected and recorded over the study period. The participants' blood samples were gathered and analyzed for Brucella infection through a variety of diagnostic The clinical assessment included an examination of symptoms, medical history, and possible exposure to Brucella. To detect specific antibodies (IgM and IgG) against Brucella present in the blood serum, serological tests such as the Serum Agglutination Test (SAT), ELISA, and Rose Bengal Test were conducted. The blood samples were analyzed to identify the Brucella bacteria through blood cultures. In addition, the presence of Brucella DNA was confirmed in various clinical samples using Polymerase Chain Reaction (PCR). The Kalkaal Hospital Research Review Board gave approval for the study protocol. Data cleaning was carried out with the help of Excel. The analysis of data was performed using SPSS software version 25.  Results: According to the analysis of the data, 30.3% of patients were men, and 69.7% of patients were women. The age ranges were 0–19: 1245 (8.1%), 20–29: 3951 (25.7%), 30-39: 3027 (19.7%), 40–49: 1786 (11.6%), and 50+: 4582. (29.9 percent). In addition, 14884 (97.0%) of the outcomes were negative, while only 465 (3.0%) were positive.  Conclusion: The research carried out at Kalkaal Hospital in Mogadishu, Somalia, has revealed important information about the prevalence of Brucella infection in the area. The results suggest that a significant number of patients have tested positive for Brucella antibodies, which indicates that the disease is a significant burden on the local population. These findings add to the global knowledge of brucellosis and emphasize its severe and long-term effects. It is important for experts in this field to have further discussions and come to a consensus on how to address this issue.

References :

1. Arenas-Gamboa AM, Rossetti CA, Chaki SP, Garcia-Gonzalez DG, Adams LG, Ficht TA. Human Brucellosis and Adverse Pregnancy Outcomes. Curr Trop Med Rep. 2016 Dec;3(4):164–72.
2. Xavier MN, Costa ÉA, Paixão TA, Santos RL. The genus Brucella and clinical manifestations of brucellosis. Cienc Rural. 2009 Aug 21;39(7):2252–60.
3. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical Manifestations of Human Brucellosis: A Systematic Review and Meta-Analysis. Carabin H, editor. PLoS Negl Trop Dis. 2012 Dec 6;6(12):e1929.
4. Tuon FF, Gondolfo RB, Cerchiari N. Human-to-human transmission of Brucella - a systematic review. Trop Med Int Health. 2017 May;22(5):539–46.
5. Mesner O, Riesenberg K, Biliar N, Borstein E, Bouhnik L, Peled N, et al. The Many Faces of Human-to-Human Transmission of Brucellosis: Congenital Infection and Outbreak of Nosocomial Disease Related to an Unrecognized Clinical Case. Clinical Infectious Diseases. 2007 Dec 15;45(12):e135–40.
6. Meltzer E, Sidi Y, Smolen G, Banai M, Bardenstein S, Schwartz E. Sexually Transmitted Brucellosis in Humans. CLIN INFECT DIS. 2010 Jul 15;51(2):e12–5.
7. Vigeant P, Mendelson J, Miller MA. Human to Human Transmission of Brucella Melitensis. Canadian Journal of Infectious Diseases. 1995;6(3):153–5.
8. Mableson HE, Okello A, Picozzi K, Welburn SC. Neglected Zoonotic Diseases—The Long and Winding Road to Advocacy. PLOS Neglected Tropical Diseases. 2014 Jun 5;8(6):e2800.
9. Kiambi SG, Fèvre EM, Omolo J, Oundo J, de Glanville WA. Risk factors for acute human brucellosis in Ijara, north-eastern Kenya. Zinsstag J, editor. PLoS Negl Trop Dis. 2020 Apr 1;14(4):e0008108.
10. Njeru J, Wareth G, Melzer F, Henning K, Pletz MW, Heller R, et al. A systematic review of brucellosis in Kenya: disease frequency in humans and animals and risk factors for human infection. BMC Public Health. 2016 Aug 22;16(1):853.
11. Yagupsky P, Morata P, Colmenero JD. Laboratory Diagnosis of Human Brucellosis. Clin Microbiol Rev. 2019 Dec 18;33(1):e00073-19.
12. Aloufi AD, Memish ZA, Assiri AM, McNabb SJN. Trends of reported human cases of brucellosis, Kingdom of Saudi Arabia, 2004–2012. JEGH. 2015;6(1):11.
13. Zeinalian Dastjerdi M, Fadaei Nobari R, Ramazanpour J. Epidemiological features of human brucellosis in central Iran, 2006–2011. Public Health. 2012 Dec;126(12):1058–62.